{"id":1123,"date":"2021-04-01T10:56:40","date_gmt":"2021-04-01T08:56:40","guid":{"rendered":"https:\/\/lensounds.com\/2021\/04\/01\/atonco-announces-the-appointment-of-adrien-reymond-as-ra-qa-director\/"},"modified":"2026-03-06T18:31:08","modified_gmt":"2026-03-06T17:31:08","slug":"atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director","status":"publish","type":"post","link":"https:\/\/atonco-pharma.com\/en\/2021\/04\/01\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\/","title":{"rendered":"ATONCO ANNOUNCES THE APPOINTMENT OF ADRIEN REYMOND AS DIRECTOR OF REGULATORY AFFAIRS AND QUALITY ASSURANCE"},"content":{"rendered":"\n<p>Atonco today announces that <strong>Adrien Reymond, PharmD, B.Eng and EMBA candidate<\/strong>, will lead regulatory affairs and quality.<\/p>\n\n\n\n<p>Adrien brings 15 years of experience in the radiopharmaceutical industry, including at AAA (a Novartis company), PETNET Solutions (a Siemens company), Atlanpole Biotherapies, and as a consultant for innovative radiopharmaceutical companies. He will be responsible for pharmaceutical, regulatory, and quality assurance affairs, ensuring compliance with Good Clinical Practices (GCP) and overseeing preparation for ISO 9001:2015 certification.<\/p>\n\n\n\n<p>The entire Atonco team is delighted to welcome Adrien Reymond to the company, both for his expertise and experience in the radiopharmaceutical industry and for his enthusiasm in joining the Atonco adventure.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">About ATONCO<\/h3>\n\n\n\n<p>ATONCO is a French private company developing molecularly targeted radiopharmaceutical products for oncological applications. Originating from the world-class nuclear medicine centre in Nantes, ATONCO and its partners are committed to the clinical use of alpha-emitting radionuclides, particularly astatine-211 (\u00b2\u00b9\u00b9At).<\/p>\n\n\n\n<p>For more information, visit <a href=\"http:\/\/www.atonco-pharma.com\/\">www.atonco-pharma.com<\/a><\/p>\n\n\n\n<p><a href=\"\/wp-content\/uploads\/2025\/11\/2021-04-01_ATONCO_Adrien_Reymond.pdf\">PDF Version >><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Atonco today announces that Adrien Reymond, PharmD, B.Eng and EMBA candidate, will lead regulatory affairs and quality. Adrien brings 15 years of experience in the radiopharmaceutical industry, including at AAA (a Novartis company), PETNET Solutions (a Siemens company), Atlanpole Biotherapies, and as a consultant for innovative radiopharmaceutical companies. He will be responsible for pharmaceutical, regulatory, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1124,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48],"tags":[],"class_list":["post-1123","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-atonco-press-releases"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Atonco Appoints Adrien Reymond as Director of Regulatory Affairs and Quality Assurance<\/title>\n<meta name=\"description\" content=\"Atonco names Adrien Reymond, PharmD, with 15 years of radiopharmaceutical industry experience, as Director of Regulatory Affairs and Quality.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/atonco-pharma.com\/en\/2021\/04\/01\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Atonco Appoints Adrien Reymond as Director of Regulatory Affairs and Quality Assurance\" \/>\n<meta property=\"og:description\" content=\"Atonco names Adrien Reymond, PharmD, with 15 years of radiopharmaceutical industry experience, as Director of Regulatory Affairs and Quality.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/atonco-pharma.com\/en\/2021\/04\/01\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\/\" \/>\n<meta property=\"og:site_name\" content=\"Atonco\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-01T08:56:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-06T17:31:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2021\/04\/adrien-612.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin27\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin27\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2021\\\/04\\\/01\\\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2021\\\/04\\\/01\\\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\\\/\"},\"author\":{\"name\":\"admin27\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/0abcc6ce783094b44c1902ff2a9283b5\"},\"headline\":\"ATONCO ANNOUNCES THE APPOINTMENT OF ADRIEN REYMOND AS DIRECTOR OF REGULATORY AFFAIRS AND QUALITY ASSURANCE\",\"datePublished\":\"2021-04-01T08:56:40+00:00\",\"dateModified\":\"2026-03-06T17:31:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2021\\\/04\\\/01\\\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\\\/\"},\"wordCount\":169,\"image\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2021\\\/04\\\/01\\\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/adrien-612.jpg\",\"articleSection\":[\"Atonco press release\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2021\\\/04\\\/01\\\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\\\/\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2021\\\/04\\\/01\\\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\\\/\",\"name\":\"Atonco Appoints Adrien Reymond as Director of Regulatory Affairs and Quality Assurance\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2021\\\/04\\\/01\\\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2021\\\/04\\\/01\\\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/adrien-612.jpg\",\"datePublished\":\"2021-04-01T08:56:40+00:00\",\"dateModified\":\"2026-03-06T17:31:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/0abcc6ce783094b44c1902ff2a9283b5\"},\"description\":\"Atonco names Adrien Reymond, PharmD, with 15 years of radiopharmaceutical industry experience, as Director of Regulatory Affairs and Quality.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2021\\\/04\\\/01\\\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2021\\\/04\\\/01\\\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2021\\\/04\\\/01\\\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\\\/#primaryimage\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/adrien-612.jpg\",\"contentUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/adrien-612.jpg\",\"width\":300,\"height\":300},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2021\\\/04\\\/01\\\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ATONCO ANNOUNCES THE APPOINTMENT OF ADRIEN REYMOND AS DIRECTOR OF REGULATORY AFFAIRS AND QUALITY ASSURANCE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/\",\"name\":\"Atonco\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/0abcc6ce783094b44c1902ff2a9283b5\",\"name\":\"admin27\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g\",\"caption\":\"admin27\"},\"sameAs\":[\"https:\\\/\\\/pulsheart-medical.com\"],\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/author\\\/admin27\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Atonco Appoints Adrien Reymond as Director of Regulatory Affairs and Quality Assurance","description":"Atonco names Adrien Reymond, PharmD, with 15 years of radiopharmaceutical industry experience, as Director of Regulatory Affairs and Quality.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/atonco-pharma.com\/en\/2021\/04\/01\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\/","og_locale":"en_US","og_type":"article","og_title":"Atonco Appoints Adrien Reymond as Director of Regulatory Affairs and Quality Assurance","og_description":"Atonco names Adrien Reymond, PharmD, with 15 years of radiopharmaceutical industry experience, as Director of Regulatory Affairs and Quality.","og_url":"https:\/\/atonco-pharma.com\/en\/2021\/04\/01\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\/","og_site_name":"Atonco","article_published_time":"2021-04-01T08:56:40+00:00","article_modified_time":"2026-03-06T17:31:08+00:00","og_image":[{"width":300,"height":300,"url":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2021\/04\/adrien-612.jpg","type":"image\/jpeg"}],"author":"admin27","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin27","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/atonco-pharma.com\/en\/2021\/04\/01\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\/#article","isPartOf":{"@id":"https:\/\/atonco-pharma.com\/en\/2021\/04\/01\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\/"},"author":{"name":"admin27","@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/0abcc6ce783094b44c1902ff2a9283b5"},"headline":"ATONCO ANNOUNCES THE APPOINTMENT OF ADRIEN REYMOND AS DIRECTOR OF REGULATORY AFFAIRS AND QUALITY ASSURANCE","datePublished":"2021-04-01T08:56:40+00:00","dateModified":"2026-03-06T17:31:08+00:00","mainEntityOfPage":{"@id":"https:\/\/atonco-pharma.com\/en\/2021\/04\/01\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\/"},"wordCount":169,"image":{"@id":"https:\/\/atonco-pharma.com\/en\/2021\/04\/01\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\/#primaryimage"},"thumbnailUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2021\/04\/adrien-612.jpg","articleSection":["Atonco press release"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/atonco-pharma.com\/en\/2021\/04\/01\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\/","url":"https:\/\/atonco-pharma.com\/en\/2021\/04\/01\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\/","name":"Atonco Appoints Adrien Reymond as Director of Regulatory Affairs and Quality Assurance","isPartOf":{"@id":"https:\/\/atonco-pharma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/atonco-pharma.com\/en\/2021\/04\/01\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\/#primaryimage"},"image":{"@id":"https:\/\/atonco-pharma.com\/en\/2021\/04\/01\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\/#primaryimage"},"thumbnailUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2021\/04\/adrien-612.jpg","datePublished":"2021-04-01T08:56:40+00:00","dateModified":"2026-03-06T17:31:08+00:00","author":{"@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/0abcc6ce783094b44c1902ff2a9283b5"},"description":"Atonco names Adrien Reymond, PharmD, with 15 years of radiopharmaceutical industry experience, as Director of Regulatory Affairs and Quality.","breadcrumb":{"@id":"https:\/\/atonco-pharma.com\/en\/2021\/04\/01\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/atonco-pharma.com\/en\/2021\/04\/01\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/atonco-pharma.com\/en\/2021\/04\/01\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\/#primaryimage","url":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2021\/04\/adrien-612.jpg","contentUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2021\/04\/adrien-612.jpg","width":300,"height":300},{"@type":"BreadcrumbList","@id":"https:\/\/atonco-pharma.com\/en\/2021\/04\/01\/atonco-announces-appointment-adrien-reymond-regulatory-affairs-quality-assurance-director\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/atonco-pharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"ATONCO ANNOUNCES THE APPOINTMENT OF ADRIEN REYMOND AS DIRECTOR OF REGULATORY AFFAIRS AND QUALITY ASSURANCE"}]},{"@type":"WebSite","@id":"https:\/\/atonco-pharma.com\/en\/#website","url":"https:\/\/atonco-pharma.com\/en\/","name":"Atonco","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/atonco-pharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/0abcc6ce783094b44c1902ff2a9283b5","name":"admin27","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g","caption":"admin27"},"sameAs":["https:\/\/pulsheart-medical.com"],"url":"https:\/\/atonco-pharma.com\/en\/author\/admin27\/"}]}},"_links":{"self":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1123","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/comments?post=1123"}],"version-history":[{"count":9,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1123\/revisions"}],"predecessor-version":[{"id":1175,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1123\/revisions\/1175"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/media\/1124"}],"wp:attachment":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/media?parent=1123"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/categories?post=1123"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/tags?post=1123"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}